VEGFA and Alzheimer disease: Regarding the study of VEGFA in AD, higher-baseline CSF VEGFA levels are associated with slower rates of hippocampal atrophy and slower rates of cognitive decline, particularly among individuals with elevated levels of AD biomarkers [31].